KIAA0776 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.603000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.790000E-01
Normal-vs-Stage2
1.037220E-01
Normal-vs-Stage3
8.564700E-03
Normal-vs-Stage4
6.179200E-01
Stage1-vs-Stage2
1.844750E-01
Stage1-vs-Stage3
9.240100E-02
Stage1-vs-Stage4
9.645200E-01
Stage2-vs-Stage3
1.688770E-01
Stage2-vs-Stage4
2.358200E-01
Stage3-vs-Stage4
4.127800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.474050E-01
Normal-vs-AfricanAmerican
5.976000E-01
Normal-vs-Asian
1.055440E-01
Caucasian-vs-AfricanAmerican
2.657600E-01
Caucasian-vs-Asian
2.692000E-01
AfricanAmerican-vs-Asian
1.638630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.136400E-02
Normal-vs-Female
2.779400E-01
Male-vs-Female
1.443240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.552200E-02
Normal-vs-Age(41-60Yrs)
3.696400E-01
Normal-vs-Age(61-80Yrs)
9.132100E-02
Normal-vs-Age(81-100Yrs)
2.167600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.670800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.089400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.350600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.003700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.470800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.875200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.124300E-02
Normal-vs-Daily Drinker
8.004400E-03
Normal-vs-Weekly Drinker
1.062350E-02
Normal-vs-Occasional Drinker
4.180400E-01
Normal-vs-Social Drinker
5.543600E-01
Non Drinker-vs-Daily Drinker
1.046980E-01
Non Drinker-vs-Weekly Drinker
3.348000E-01
Non Drinker-vs-Occasional Drinker
2.276800E-01
Non Drinker-vs-Social Drinker
1.548390E-01
Daily Drinker-vs-Weekly Drinker
6.232600E-01
Daily Drinker-vs-Occasional Drinker
3.288100E-02
Daily Drinker-vs-Social Drinker
2.701600E-02
Weekly Drinker-vs-Occasional Drinker
7.715900E-02
Weekly Drinker-vs-Social Drinker
5.643800E-02
Occasional Drinker-vs-Social Drinker
7.533800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.326100E-02
Normal-vs-Grade 2
2.737700E-02
Normal-vs-Grade 3
5.024000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.294800E-01
Grade 1-vs-Grade 3
3.350400E-01
Grade 1-vs-Grade 4
7.326100E-02
Grade 2-vs-Grade 3
4.194800E-01
Grade 2-vs-Grade 4
2.737700E-02
Grade 3-vs-Grade 4
5.024000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.036200E-02
Normal-vs-NonDiabetic
8.110100E-02
Diabetic-vs-NonDiabetic
3.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.160400E-03
Normal-vs-NoPancreatitis
9.584300E-02
Pancreatitis-vs-NoPancreatitis
4.273800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.375400E-01
Normal-vs-N1
8.382200E-02
N0-vs-N1
4.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.853170E-01
Normal-vs-TP53-NonMutant
5.703600E-01
TP53-Mutant-vs-TP53-NonMutant
3.766000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
